Abstract
The fetus with sacrococcygeal teratoma (SCT) is at high risk for prenatal and perinatal complications. The natural history and pathophysiology of fetal SCT is different than that of postnatally diagnosed SCT, and has only recently been defined. Survival of fetuses with SCT is dependent on anticipation and recognition of pathophysiologic events, and optimal obstetric and surgical management. In a subset of fetuses with SCT, fetal resection of tumor may offer the only hope for survival.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
